The World Health Organization (WHO) has approved a vaccine made by Sinovac Biotech for emergency use listing, the second Chinese-produced shot to get its endorsement, a WHO statement said.
WHO emergency listing is a signal to national regulators on a product’s safety and efficacy.
“The world desperately needs multiple COVID-19 vaccines to address the huge access inequity across the globe,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products. “We urge manufacturers to participate in the COVAX Facility, share their knowhow and data and contribute to bringing the pandemic under control.”
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems due to India’s suspension of vaccine exports.
COVID-19 pandemic has infected more than 171 million people and claimed at least 3.5 million lives across the world.